Lisa-Jane K. Hunter
Impact in
-
- PI3K/AKT/mTOR signaling in cancer
- Biochemical and Molecular Research
- Protein Kinase Regulation and GTPase Signaling
- TGF-β signaling in diseases
-
- Cancer-related Molecular Pathways
Papers in
-
- Biochemical and Molecular Research 3
- PI3K/AKT/mTOR signaling in cancer 3
- Metabolism, Diabetes, and Cancer 2
- Enzyme function and inhibition 1
- Epigenetics and DNA Methylation 1
-
- Cancer Mechanisms and Therapy 3
- Co-authors
- Michelle D. Garrett (5 shared papers)Christine S. L. Lee (2 shared papers)Alexander Swarbrick (2 shared papers)Elizabeth A. Musgrove (2 shared papers)Robert L. Sutherland (2 shared papers)Paul Workman (4 shared papers)Ian Collins (3 shared papers)Thomas G. Davies (3 shared papers)
- Journals
- Molecular Cancer Therapeutics (2 papers)Bioorganic & Medicinal Chemistry (1 paper)Journal of Medicinal Chemistry (1 paper)Assay and Drug Development Technologies (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Lisa-Jane K. Hunter
7 papers receiving 318 citations
Peers
Comparison fields: 5 of 54
- Molecular Biology 236
- Oncology 77
- Pathology and Forensic Medicine 39
- Cancer Research 31
- Organic Chemistry 63
Countries citing papers authored by Lisa-Jane K. Hunter
This map shows the geographic impact of Lisa-Jane K. Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa-Jane K. Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa-Jane K. Hunter more than expected).
Fields of papers citing papers by Lisa-Jane K. Hunter
This network shows the impact of papers produced by Lisa-Jane K. Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa-Jane K. Hunter. The network helps show where Lisa-Jane K. Hunter may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisa-Jane K. Hunter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 62 | |
| 2 | 2004 | 56 | |
| 3 | 2010 | 51 | |
| 4 | 2007 | 48 | |
| 5 | 2001 | 46 | |
| 6 | 2007 | 36 | |
| 7 | 2005 | 31 |
About Lisa-Jane K. Hunter
Lisa-Jane K. Hunter is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Organic Chemistry, Oncology and Cell Biology, having authored 7 papers that have together received 330 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (3 papers), Biochemical and Molecular Research (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Cancer-related Molecular Pathways (2 papers), Enzyme function and inhibition (1 paper), Epigenetics and DNA Methylation (1 paper) and Synthesis and biological activity (1 paper). The work is most often cited by research in Molecular Biology (236 citations), Oncology (77 citations), Pathology and Forensic Medicine (39 citations), Cancer Research (31 citations) and Organic Chemistry (63 citations). Lisa-Jane K. Hunter has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Michelle D. Garrett, Christine S. L. Lee, Alexander Swarbrick, Elizabeth A. Musgrove, Robert L. Sutherland, Paul Workman, Ian Collins, Thomas G. Davies, Rina Hui and Mike I. Walton. Their work appears in journals such as Molecular Cancer Therapeutics, Bioorganic & Medicinal Chemistry, Journal of Medicinal Chemistry, Assay and Drug Development Technologies and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.